Tolga Tanguler

EVP · ALNYLAM PHARMACEUTICALS, INC.

Rank #7,840 SEC EDGAR (United States) ↗ Files from United States

Details

Officer and board memberPharmaceuticals & BiotechnologyALNYSEC CIK 0001849458

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

Disclosed holdings
$9.1M
1-day change
▲ 0.61%
Positions on file
1
issuers disclosed in Forms 3/4/5 and Schedules 13D/G

Disclosed holdings over time 53 weekly points

What the 1 currently disclosed position would have been worth at each week’s closing price. A rising line means the shares got more valuable, not that this person bought more.

How the line is built

Share counts are as last reported to the SEC and held constant; only prices move.

2025-09-05$7.0M – $16.5M2026-09-04

Insider activity Jun 24, 2024 – Mar 4, 2026

Tolga Tanguler is recorded in filings to the U.S. SEC via EDGAR as officer and board member, and reported 107 transactions between Jun 24, 2024 and Mar 4, 2026. The buy and sell totals below count only codes P, S.

Why the other codes are excluded

Share awards (A), shares withheld to pay tax (F), option exercises (M) and gifts (G) also appear in the table, but they are consequences of a pay package or a private transfer, not a decision to buy or sell on the open market. Counting them would turn this into a compensation ranking.

Open-market buys (code P)
None
0 purchases on file
Open-market sales (code S)
$6.23M
97 sales on file priced rows only
All reported transactions
107
every code, including awards and exercises
Pattern
Net seller in the final 12 months of the window
last 12 months of the window

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

Tolga Tanguler sold 1,959 ALNYLAM PHARMACEUTICALS, INC. (ALNY) shares for $607,447 on Feb 13, 2026

Large trade for this person

Flagged because this trade was large compared with this person’s own earlier open-market trades in the same currency — not because it is large in absolute terms. A trade that is routine for one insider can be flagged for another.

Tolga Tanguler sold 1,959 ALNYLAM PHARMACEUTICALS, INC. (ALNY) shares for $607,447 on Feb 13, 2026
Date Insider Transaction Shares Price Value Filing
Feb 13, 2026 Tolga Tanguler S Open-market sale 1,959 held after: 31,769 $310.08 $607,447 SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Tolga Tanguler sold 2,869 ALNYLAM PHARMACEUTICALS, INC. (ALNY) shares for $1,285,508 on Aug 29, 2025

Large trade for this person

Flagged because this trade was large compared with this person’s own earlier open-market trades in the same currency — not because it is large in absolute terms. A trade that is routine for one insider can be flagged for another.

Tolga Tanguler sold 2,869 ALNYLAM PHARMACEUTICALS, INC. (ALNY) shares for $1,285,508 on Aug 29, 2025
Date Insider Transaction Shares Price Value Filing
Aug 29, 2025 Tolga Tanguler S Open-market sale 899 held after: 28,372 $446.98 $401,835 SEC filing ↗
Aug 29, 2025 Tolga Tanguler S Open-market sale 1,289 held after: 27,083 $448.05 $577,536 SEC filing ↗
Aug 29, 2025 Tolga Tanguler S Open-market sale 681 held after: 26,402 $449.54 $306,137 SEC filing ↗

Total of the rows above: $1,285,508, in the currency the filings report.

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Tolga Tanguler sold 543 ALNYLAM PHARMACEUTICALS, INC. (ALNY) shares for $246,544 on Aug 18, 2025

Large trade for this person

Flagged because this trade was large compared with this person’s own earlier open-market trades in the same currency — not because it is large in absolute terms. A trade that is routine for one insider can be flagged for another.

Tolga Tanguler sold 543 ALNYLAM PHARMACEUTICALS, INC. (ALNY) shares for $246,544 on Aug 18, 2025
Date Insider Transaction Shares Price Value Filing
Aug 18, 2025 Tolga Tanguler S Open-market sale 543 held after: 29,719 $454.04 $246,544 SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Tolga Tanguler sold 471 ALNYLAM PHARMACEUTICALS, INC. (ALNY) shares for $114,820 on Mar 3, 2025

Unusual change in a direct holding

Flagged because the change that day in the shares this person holds directly was unusually large compared with their own earlier changes. The rows below are the open-market trades reported that day; under each share count is the balance the filing reports after that line.

Tolga Tanguler sold 471 ALNYLAM PHARMACEUTICALS, INC. (ALNY) shares for $114,820 on Mar 3, 2025
Date Insider Transaction Shares Price Value Filing
Mar 3, 2025 Tolga Tanguler S Open-market sale 96 held after: 28,113 $244.41 $23,463 SEC filing ↗
Mar 3, 2025 Tolga Tanguler S Open-market sale 70 held after: 28,043 $245.26 $17,168 SEC filing ↗
Mar 3, 2025 Tolga Tanguler S Open-market sale 29 held after: 28,014 $246.18 $7,139 SEC filing ↗
Mar 3, 2025 Tolga Tanguler S Open-market sale 142 held after: 28,209 $243.36 $34,557 SEC filing ↗
Mar 3, 2025 Tolga Tanguler S Open-market sale 3 held after: 28,011 $247.35 $742 SEC filing ↗
Mar 3, 2025 Tolga Tanguler S Open-market sale 131 held after: 28,351 $242.37 $31,750 SEC filing ↗

Total of the rows above: $114,820, in the currency the filings report.

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Reported transactions

Price 0.00 is a real reported figure on gifts (G) and share awards (A) — not a missing number. The 25 most recent rows are grouped into 7 lines by date, company and transaction type — open a line to see every lot with its own source link. We hold 107 on file in total. See the full history on EDGAR ↗

How to read this list

Every row is one line of one Form 4 or Form 5, with the filing it came from. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. ALNYLAM PHARMACEUTICALS, INC. ALNY S Open-market sale × 8 2,309 shares $746.0K
    The 8 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    208 $325.67 $67.7K SEC filing ↗
    106 $319.03 $33.8K SEC filing ↗
    350 $323.01 $113.1K SEC filing ↗
    272 $324.88 $88.4K SEC filing ↗
    767 $323.84 $248.4K SEC filing ↗
    102 $320.01 $32.6K SEC filing ↗
    215 $320.81 $69.0K SEC filing ↗
    289 $321.82 $93.0K SEC filing ↗
  2. ALNYLAM PHARMACEUTICALS, INC. ALNY S Open-market sale × 10 1,598 shares $523.6K
    The 10 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    47 $323.62 $15.2K SEC filing ↗
    170 $329.71 $56.1K SEC filing ↗
    81 $330.85 $26.8K SEC filing ↗
    94 $331.93 $31.2K SEC filing ↗
    37 $332.64 $12.3K SEC filing ↗
    90 $324.65 $29.2K SEC filing ↗
    258 $325.63 $84.0K SEC filing ↗
    392 $326.81 $128.1K SEC filing ↗
    329 $327.67 $107.8K SEC filing ↗
    100 $328.71 $32.9K SEC filing ↗
  3. ALNYLAM PHARMACEUTICALS, INC. ALNY A Grant or awardnot a buy/sell decisionreported at zero 4,769 shares $0 at $0.00 SEC filing ↗
  4. ALNYLAM PHARMACEUTICALS, INC. ALNY M Option exercise or conversionnot a buy/sell decisionreported at zero 1,666 shares $0 at $0.00 SEC filing ↗
  5. ALNYLAM PHARMACEUTICALS, INC. ALNY S Open-market sale 1,959 shares $607.4K at $310.08 SEC filing ↗
  6. ALNYLAM PHARMACEUTICALS, INC. ALNY A Grant or awardnot a buy/sell decisionreported at zero 4,000 shares $0 at $0.00 SEC filing ↗
  7. ALNYLAM PHARMACEUTICALS, INC. ALNY S Open-market sale × 3 72 shares $26.2K
    The 3 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    39 $353.95 $13.8K SEC filing ↗
    19 $375.65 $7.1K SEC filing ↗
    14 $374.44 $5.2K SEC filing ↗

Disclosed holdings

Shares is the amount on the form; value is that amount times the closing price shown. Rows with no closing price are left blank, so they may add up to less than the headline figure.

What is not counted here

Each row is one filing you can open. Private companies, real estate, bonds and crypto are not in SEC insider filings and are therefore not counted here.

Equity positions disclosed to the SEC, with the source filing behind each row.
Issuer Ticker Security Shares Close Value Form Reported Filing
ALNYLAM PHARMACEUTICALS, INC. ALNY Common Stock 34,297 $266.11 $9.1M 4 EDGAR ↗

Other insiders at the same companies

People who also file with the SEC at a company where Tolga Tanguler reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

The filings linked in the tables above are the sources for every figure on this page.

Think a number here is wrong? Open the linked filing and compare — how to report it.

Profile record last refreshed Sep 8, 2026.

Logo credits

Logo credits. Logos on this page are shown to identify the company they belong to; trademarks remain the property of their owner. Files whose licence requires naming the author are listed here. Logos in the public domain or released under CC0 are not listed, because those licences ask for nothing.

ALNYLAM PHARMACEUTICALS, INC.: Alnylam Pharmaceuticals / CC BY-SA 3.0, via Wikimedia Commons ↗